These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25938755)

  • 1. Clonality and Antimicrobial Susceptibility of Burkholderia cepacia complex Isolates Collected from Cystic Fibrosis Patients during 1998-2013 in Bern, Switzerland.
    Lupo A; Isis E; Tinguely R; Endimiani A
    New Microbiol; 2015 Apr; 38(2):281-8. PubMed ID: 25938755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species.
    Abbott FK; Milne KE; Stead DA; Gould IM
    Int J Antimicrob Agents; 2016 Nov; 48(5):521-527. PubMed ID: 27665523
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Van Dalem A; Herpol M; Echahidi F; Peeters C; Wybo I; De Wachter E; Vandamme P; Piérard D
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal diversity among Burkholderia cepacia complex isolates from cystic fibrosis patients in a reference unit.
    Barrado L; Martinez MT; Villa J; Orellana MÁ; Viedma E; Chaves F
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):665-8. PubMed ID: 23850187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
    Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre.
    Golini G; Cazzola G; Fontana R
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):175-80. PubMed ID: 16501927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkholderia cepacia complex infection in an Adult Cystic Fibrosis unit in Madrid.
    Correa-Ruiz A; Girón R; Buendía B; Medina-Pascual MJ; Valenzuela C; López-Brea M; Sáez-Nieto JA
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):649-54. PubMed ID: 23528342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.
    Power RF; Linnane B; Martin R; Power N; Harnett P; Casserly B; O'Connell NH; Dunne CP
    BMC Pulm Med; 2016 Apr; 16(1):57. PubMed ID: 27103163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel glycopolymer sensitizes Burkholderia cepacia complex isolates from cystic fibrosis patients to tobramycin and meropenem.
    Narayanaswamy VP; Giatpaiboon S; Baker SM; Wiesmann WP; LiPuma JJ; Townsend SM
    PLoS One; 2017; 12(6):e0179776. PubMed ID: 28662114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis.
    Lambiase A; Raia V; Stefani S; Sepe A; Ferri P; Buonpensiero P; Rossano F; Del Pezzo M
    J Microbiol; 2007 Jun; 45(3):275-9. PubMed ID: 17618236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H; Lenney W; Gilchrist FJ
    BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain.
    Medina-Pascual MJ; Valdezate S; Villalón P; Garrido N; Rubio V; Saéz-Nieto JA
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3385-96. PubMed ID: 22855365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multilocus sequence analysis, biofilm production, antibiotic susceptibility and synergy tests of Burkholderia species in patients with and without cystic fibrosis].
    Akışoğlu Ö; Engin D; Sarıçam S; Müştak HK; Şener B; Hasçelik G
    Mikrobiyol Bul; 2019 Jan; 53(1):22-36. PubMed ID: 30683036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Antimicrobial Susceptibility Testing Methods for Burkholderia cenocepacia and Burkholderia multivorans Isolates from Cystic Fibrosis Patients.
    Huse HK; Lee MJ; Wootton M; Sharp SE; Traczewski M; LiPuma JJ; Jorth P
    J Clin Microbiol; 2021 Nov; 59(12):e0144721. PubMed ID: 34524889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
    Kennedy S; Beaudoin T; Yau YC; Caraher E; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
    Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of
    Schaumburg F; Idelevich EA; Mellmann A; Kahl BC
    Microb Drug Resist; 2022 May; 28(5):545-550. PubMed ID: 35512733
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Mazer DM; Young C; Kalikin LM; Spilker T; LiPuma JJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.